Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
200
-
Total 13F shares, excl. options
-
49.3M
-
Shares change
-
-2.55M
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
-$87.1M
-
Put/Call ratio
-
0.37
-
Number of buys
-
111
-
Number of sells
-
-94
-
Price
-
$32.77
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q3 2023
246 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q3 2023.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 200 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.3M shares
of 57.1M outstanding shares and own 86.32% of the company stock.
Largest 10 shareholders include Valor Management LLC (11.2M shares), BlackRock Inc. (6.13M shares), FMR LLC (5.45M shares), VANGUARD GROUP INC (3.68M shares), Vivo Capital, LLC (2.61M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.42M shares), STATE STREET CORP (1.23M shares), venBio Partners LLC (1.04M shares), PERCEPTIVE ADVISORS LLC (996K shares), and MACQUARIE GROUP LTD (952K shares).
This table shows the top 200 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.